Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal System Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003544
What this trial is testing

Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04150744
What this trial is testing

RFA Plus Carrizumab vs Carrizumab Alone for HCC

Who this might be right for
Tumor ImmunityImmunosuppressionRadiofrequency Ablation
Second Affiliated Hospital, Zhejiang University, School of Medicine 120
Large-scale testing (Phase 3)UnknownNCT00610636
What this trial is testing

Treatment Outcomes of Hepatic Metastasis After FOLFOX-4 Therapy

Who this might be right for
Colorectal Cancer
National Taiwan University Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT02780700
What this trial is testing

Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]

Who this might be right for
Colorectal Neoplasms
Boehringer Ingelheim 1
Early research (Phase 1)Study completedNCT03132792
What this trial is testing

AFPᶜ³³²T in Advanced HCC

Who this might be right for
Hepatocellular CancerAFP Expressing Tumors
Adaptimmune 39
Testing effectiveness (Phase 2)UnknownNCT00839111
What this trial is testing

Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment

Who this might be right for
Colorectal Neoplasms
Fudan University 43
Not applicableStudy completedNCT03489707
What this trial is testing

The Prevent Anal Cancer Self-Swab Study

Who this might be right for
Anal Cancer
Medical College of Wisconsin 253
Not applicableLooking for participantsNCT07605611
What this trial is testing

Somatostatin Plus Clear Liquid Diet Versus Diverting Stoma in Patients With Rectal Cancer Undergoing Ultra-Low Anterior Resection

Who this might be right for
Rectal CancerAnastomotic Leakage
Tongji Hospital 72
Post-approval studies (Phase 4)Study completedNCT00441311
What this trial is testing

Dissemination of Colorectal Cancer Screening to Primary Care Physicians

Who this might be right for
Colorectal Cancer
Columbia University 264
Not applicableStudy completedNCT03035071
What this trial is testing

Morbidity in Open Versus Minimally Invasive Esophagectomy

Who this might be right for
Esophageal Cancer
Austrian Society Of Surgical Oncology 26
Large-scale testing (Phase 3)Study completedNCT01936467
What this trial is testing

Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) in Solid Pancreatic Lesions

Who this might be right for
Pancreatic Solid LesionsPancreatic Mass
Johns Hopkins University 121
Post-approval studies (Phase 4)Study completedNCT00140036
What this trial is testing

Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

Who this might be right for
Colorectal Neoplasms
Pfizer 137
Not applicableStudy completedNCT00877136
What this trial is testing

A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®

Who this might be right for
Liver TumorsHepatocellular CarcinomaHepatoma+1 more
St. Joseph Hospital of Orange 18
Not applicableActive Not RecruitingNCT02531607
What this trial is testing

Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)

Who this might be right for
Pancreatic Neoplasms
AdventHealth 500
Testing effectiveness (Phase 2)WithdrawnNCT01600807
What this trial is testing

OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer, Metastatic
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00964171
What this trial is testing

Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Institut Bergonié 19
Testing effectiveness (Phase 2)WithdrawnNCT00725400
What this trial is testing

Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma

Who this might be right for
Colorectal Carcinoma
American Scitech International 450
Not applicableStudy completedNCT06244836
What this trial is testing

Comparison of Two Bundles of Care to Reduce Surgical Site Infection in Colorectal Surgery (CCR-VINCat 2)

Who this might be right for
Colon CancerRectal CancerSurgical Site Infection
Hospital de Granollers 32,205
Not applicableStudy completedNCT06980792
What this trial is testing

Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases

Who this might be right for
Pancreas NeoplasmsLiver MetastasisPancreas Ductal Adenocarcinoma+3 more
Azienda Ospedaliero-Universitaria di Modena 90
Not applicableStudy completedNCT02322736
What this trial is testing

Prospective Observational Study of 1st and 2nd Line Vectibix® Use in RAS-wt mCRC Pts to Evaluate Pattern of Use and ORR

Who this might be right for
Metastatic Colorectal Cancer
Amgen 218
Next Page